Editas Medicine, Inc. (EDIT)
2.62
+0.10
(+3.97%)
USD |
NASDAQ |
Oct 02, 16:00
2.60
-0.02
(-0.76%)
After-Hours: 20:00
Editas Medicine Max Drawdown (5Y) : 98.92% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 98.92% |
| August 31, 2026 | 98.92% |
| July 31, 2026 | 98.92% |
| June 30, 2026 | 98.92% |
| May 31, 2026 | 98.92% |
| April 30, 2026 | 98.92% |
| March 31, 2026 | 98.92% |
| February 28, 2026 | 98.92% |
| January 31, 2026 | 98.92% |
| December 31, 2025 | 98.92% |
| November 30, 2025 | 98.92% |
| October 31, 2025 | 98.92% |
| September 30, 2025 | 98.92% |
| August 31, 2025 | 98.92% |
| July 31, 2025 | 98.92% |
| June 30, 2025 | 98.92% |
| May 31, 2025 | 98.92% |
| April 30, 2025 | 98.92% |
| March 31, 2025 | 98.74% |
| February 28, 2025 | 98.74% |
| January 31, 2025 | 98.74% |
| December 31, 2024 | 98.68% |
| November 30, 2024 | 97.57% |
| October 31, 2024 | 96.80% |
| September 30, 2024 | 96.26% |
| Date | Value |
|---|---|
| August 31, 2024 | 95.94% |
| July 31, 2024 | 94.99% |
| June 30, 2024 | 94.84% |
| May 31, 2024 | 94.44% |
| April 30, 2024 | 94.25% |
| March 31, 2024 | 93.10% |
| February 29, 2024 | 93.10% |
| January 31, 2024 | 93.10% |
| December 31, 2023 | 93.10% |
| November 30, 2023 | 93.10% |
| October 31, 2023 | 93.10% |
| September 30, 2023 | 92.98% |
| August 31, 2023 | 92.98% |
| July 31, 2023 | 92.98% |
| June 30, 2023 | 92.98% |
| May 31, 2023 | 92.98% |
| April 30, 2023 | 92.98% |
| March 31, 2023 | 92.24% |
| February 28, 2023 | 91.38% |
| January 31, 2023 | 91.38% |
| December 31, 2022 | 90.81% |
| November 30, 2022 | 89.10% |
| October 31, 2022 | 88.97% |
| September 30, 2022 | 88.97% |
| August 31, 2022 | 88.97% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Recursion Pharmaceuticals, Inc. | 93.13% |
| Geron Corp. | 84.48% |
| Halozyme Therapeutics, Inc. | 49.06% |
| Novavax, Inc. | 98.82% |
| AVITA Medical, Inc. | 88.49% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -66.35 |
| Beta (5Y) | 2.001 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 81.66% |
| Historical Sharpe Ratio (5Y) | -0.5675 |
| Historical Sortino (5Y) | -1.179 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.89% |